Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Glenn J. Krevlin Boosts His Stake in Jamba, Inc. (JMBA)

Glenn J. Krevlin’s Glenhill Advisors revealed in a filing that it has increased its position in Jamba, Inc. (NASDAQ:JMBA) to 888,155 shares from 369,009 shares held earlier. The stake equals to 5.2% of the common stock.

Jamba, Inc. (NASDAQ:JMBA)

Jamba, Inc. (NASDAQ:JMBA) is a restaurant retailer of better-for-you, specialty beverage and food offerings, with over 851 Jamba Juice store across the globe, recorded as of December 2013.

A couple of weeks back, Jamba, Inc. (NASDAQ:JMBA) reiterated FY2013 guidance, including comparable store sales guidance range of flat to 1%. For FY14 the company expects to deliver company-owned comparable store sales of 2%-4%, store- level margin of 18% to 19%. It will add 1,000 JambaGO™ machine sites and attain income from operations of 2.0% to 3.0%. An improvement of 1% to 2% in operating margins is expected, due to enterprise-wide cost savings initiative.

Earlier, Christopher Shackelton and Adam Gray‘s hedge fund Coliseum Capital disclosed holding a total of 6.1% of the Jamba, Inc. (NASDAQ:JMBA) common stock, its holding amassing over 1.05 million shares.

Millennium Management, led by Israel Englander, also holds 93,408 shares with a reported value of $1.25 million. Mark N. Diker’s Diker Management, is also bullish on Jamba, Inc. (NASDAQ:JMBA), adding the stock to its equity portfolio in the third quarter of 2013.

Glenhill Advisors follows a long/short equity strategy, with a focus on small cap companies.

One of the other company where the fund has shown an acute interest is Lionbridge Technologies, Inc. (NASDAQ:LIOX), where the fund initiated a position in May 2013 and has since then boosted its stake in the company by 1 million shares. It further increased its holding from 8.78 million shares in October to 8.86 million shares in November.

Earlier, the fund also disclosed raising its ownership in Yongye International, Inc (NASDAQ:YONG) to 1.94 million shares. The holding represents a 3.8% stake of the company.

At the end of the third quarter of 2013 the fund had the largest portion of its equity portfolio invested in  Motorola Solutions Inc (NYSE:MSI), worth $57.60 million.

Disclosure: none

Recommended Reading:

Broadwood Capital Trims Its Stake in Questcor Pharmaceuticals Inc (QCOR)

Hedge Fund News: Rob Citrone, David Tepper & Paul Singer

Is Icahn Buying eBay Inc (EBAY) Options?

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!